Stock 600420 SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shanghai Shyndec Pharmaceutical Co., Ltd.

Equities

600420

CNE000001JG2

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
10.88 CNY +2.93% Intraday chart for Shanghai Shyndec Pharmaceutical Co., Ltd. +1.87% +11.13%
29/04 Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
16/04 Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets MT

Business Summary

SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The Company also offers topical preparations, such as gynecological suppositories and dermatology preparations.

Number of employees: 11,608

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
- - 12,070 100.0 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
79.2 %
10,321 80.6 % 9,390 79.2 % -9.02%
Overseas
20.8 %
2,489 19.4 % 2,467 20.8 % -0.88%

Managers

Managers TitleAgeSince
Wan Yong Lian PSD
 President 54 24/22/24
Hao Li DFI
 Director of Finance/CFO 59 18/16/18
Qian Yin Jing IRC
 Investor Relations Contact 44 13/19/13
Dong Song Wei SEC
 Corporate Secretary 51 18/11/18
Zhong Gong PRN
 Corporate Officer/Principal 60 08/07/08

Members of the board

Members of the board TitleAgeSince
Yong Gang Xing CHM
 Chairman 48 25/19/25
Yong Liu BRD
 Director/Board Member 55 17/21/17
Shu Yuan Wei BRD
 Director/Board Member 60 29/20/29
Ying Qi Li BRD
 Director/Board Member 48 28/22/28
Ru Li BRD
 Director/Board Member 45 28/22/28
Wan Yong Lian PSD
 President 54 24/22/24
Xiang Dong Yu BRD
 Director/Board Member 60 31/19/31
Peng Wang BRD
 Director/Board Member 42 28/22/28
Kan Tian BRD
 Director/Board Member 61 13/19/13
Yong Hua Zuo BRD
 Director/Board Member 48 28/22/28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,341,172,692 531,660,612 ( 39.64 %) 0 39.64 %

Shareholders

NameEquities%Valuation
China State-Owned Assets Supervision & Admn Commission
30.83 %
413,518,181 30.83 % 512 M ¥
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.
12.46 %
167,142,202 12.46 % 207 M ¥
China Merchants Fund Management Co., Ltd.
1.440 %
19,316,184 1.440 % 24 M ¥
SINOPHARM GROUP CO. LTD.
1.422 %
19,068,440 1.422 % 24 M ¥
Yan Lin Han
1.292 %
17,326,019 1.292 % 21 M ¥
Shandong State-Owned Asset Sup. & Adm. Commission
1.181 %
15,834,626 1.181 % 20 M ¥
Shanghai Guangci Medicine High-Tech Co. Ltd.
0.9335 %
12,520,000 0.9335 % 15 M ¥
Caitong Securities Asset Management Co., Ltd.
0.7464 %
10,011,000 0.7464 % 12 M ¥
Monetary Authority of Macao (Investment Management)
0.6911 %
9,268,650 0.6911 % 11 M ¥
JPMorgan Asset Management (China) Co Ltd.
0.6223 %
8,346,416 0.6223 % 10 M ¥
NameEquities%Valuation
China State-Owned Assets Supervision & Admn Commission
100.00 %
145,102,781 100.00 % 179 M ¥

Company contact information

Shanghai Shyndec Pharmaceutical Co., Ltd.

378 Jianlu Road Pudong New Area

200137, Shanghai

+86 21 6251 0990

http://www.shyndec.com
address Shanghai Shyndec Pharmaceutical Co., Ltd.(600420)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.88
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+11.13% 2.02B
MERCK KGAA Stock Merck KGaA
+5.38% 69.91B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+12.55% 9.24B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-12.05% 5.05B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+42.38% 4.47B
YUHAN CORPORATION Stock Yuhan Corporation
+4.65% 3.92B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-19.05% 2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.72% 2.23B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
+4.39% 1.66B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600420 Stock
  4. Company Shanghai Shyndec Pharmaceutical Co., Ltd.